ES2057225T3 - Una composicion para la preparacion de una vitamina d3 activa en forma de dosificacion y su procedimiento de preparacion. - Google Patents

Una composicion para la preparacion de una vitamina d3 activa en forma de dosificacion y su procedimiento de preparacion.

Info

Publication number
ES2057225T3
ES2057225T3 ES90104750T ES90104750T ES2057225T3 ES 2057225 T3 ES2057225 T3 ES 2057225T3 ES 90104750 T ES90104750 T ES 90104750T ES 90104750 T ES90104750 T ES 90104750T ES 2057225 T3 ES2057225 T3 ES 2057225T3
Authority
ES
Spain
Prior art keywords
preparation
composition
active vitamin
dosage form
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90104750T
Other languages
English (en)
Inventor
Masami Moroi
Toshio Yokoyama
Akira Iwasa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Application granted granted Critical
Publication of ES2057225T3 publication Critical patent/ES2057225T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

UNAS COMPOSICIONES APROPIADAS PARA USAR EN LA PREPARACION DE DICHAS VITAMINAS SON DISPUESTAS. CADA COMPOSICION COMPREND EUNA VITAMINA ACTIVA D3 Y UN ESTABILIZADOR SELECCIONADO DE DIETILAMINOACETATO PROLIVINILACETAL E HIDROXIPROPILCELUSOSA. TAMBIEN ESTAN DISPUESTOS LOS PRECESOS PARA LA PREPARACION DE LAS VITAMINAS. CADA PROCESO COMPRENDE LA ADICION DEL ESTABILIZADOR YA MENCIONADO A LA VITAMINA Y A LA MEZCLA RESULTANTE, LA ADICION DE UN PORTADOR FARMACEUTICAMENTE ACEPTABLE.
ES90104750T 1989-03-13 1990-03-13 Una composicion para la preparacion de una vitamina d3 activa en forma de dosificacion y su procedimiento de preparacion. Expired - Lifetime ES2057225T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1060554A JPH02240024A (ja) 1989-03-13 1989-03-13 活性型ビタミンｄ↓３類製剤用組成物

Publications (1)

Publication Number Publication Date
ES2057225T3 true ES2057225T3 (es) 1994-10-16

Family

ID=13145623

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90104750T Expired - Lifetime ES2057225T3 (es) 1989-03-13 1990-03-13 Una composicion para la preparacion de una vitamina d3 activa en forma de dosificacion y su procedimiento de preparacion.

Country Status (6)

Country Link
EP (1) EP0387808B1 (es)
JP (1) JPH02240024A (es)
KR (1) KR900013964A (es)
CA (1) CA2011943A1 (es)
DE (1) DE69001573T2 (es)
ES (1) ES2057225T3 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2845342B2 (ja) * 1990-04-28 1999-01-13 大正製薬株式会社 ビタミンｄ▲下３▼誘導体含有固形製剤組成物
JPH04198129A (ja) * 1990-11-28 1992-07-17 Sumitomo Pharmaceut Co Ltd 活性型ビタミンｄ↓３類含有組成物
IL103224A (en) * 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
HUE056937T2 (hu) 2006-02-03 2022-04-28 Opko Renal Llc A D-vitamin elégtelenség és hiány kezelése 25-hidroxivitamin D2-vel és 25-hidroxivitamin D3-mal
PT2679228T (pt) 2006-06-21 2018-04-16 Opko Ireland Global Holdings Ltd Terapia utilizando um agente de repleção de vitamina d e um agente de substituição hormonal de vitamina d
US20100280064A1 (en) * 2006-12-07 2010-11-04 Tomoyuki Watanabe Pharmaceutical composition having improved storage stability
TWI482641B (zh) 2006-12-07 2015-05-01 Daiichi Sankyo Co Ltd 含有低取代度羥丙基纖維素之醫藥組成物
WO2008134523A1 (en) 2007-04-25 2008-11-06 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
PT2148684E (pt) 2007-04-25 2013-04-19 Cytochroma Inc Método de tratamento para a insuficiência e deficiência de vitamina d
KR101959952B1 (ko) 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
WO2009124210A1 (en) 2008-04-02 2009-10-08 Cytochroma Inc. Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
AU2015298858A1 (en) 2014-08-07 2017-03-02 Opko Ireland Global Holdings Ltd. Adjunctive therapy with 25-hydroxyvitamin D
JP7034595B2 (ja) * 2016-03-23 2022-03-14 株式会社ファンケル ビタミンｄ３安定化組成物
CA3018019A1 (en) 2016-03-28 2017-10-26 Opko Ireland Global Holdings, Limited Methods of vitamin d treatment
JP7085105B2 (ja) * 2016-11-10 2022-06-16 日産化学株式会社 ビタミンｄ３誘導体の製剤
JP6905538B2 (ja) * 2016-12-28 2021-07-21 中外製薬株式会社 Ｅｄ−７１の固体分散体および油分分散体を含む医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62149619A (ja) * 1985-09-05 1987-07-03 Teijin Ltd 活性型ビタミンｄ３類注射用組成物
JPS6483019A (en) * 1987-09-25 1989-03-28 Sunstar Inc Composition used in oral cavity for orthodontic therapy of tooth
JPS6425723A (en) * 1988-07-07 1989-01-27 Teijin Ltd Production of active type vitamin d3 composition
JP2525478B2 (ja) * 1989-03-01 1996-08-21 帝人株式会社 安定性の改良された活性型ビタミンｄ▲下３▼類固型製剤

Also Published As

Publication number Publication date
JPH0587050B2 (es) 1993-12-15
JPH02240024A (ja) 1990-09-25
CA2011943A1 (en) 1990-09-13
DE69001573T2 (de) 1993-08-26
EP0387808B1 (en) 1993-05-12
DE69001573D1 (de) 1993-06-17
EP0387808A3 (en) 1991-04-03
EP0387808A2 (en) 1990-09-19
KR900013964A (ko) 1990-10-22

Similar Documents

Publication Publication Date Title
ES2057225T3 (es) Una composicion para la preparacion de una vitamina d3 activa en forma de dosificacion y su procedimiento de preparacion.
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
PT100234A (pt) Novos esteres de alcoois aminados biciclicos e triciclicos, processo para a sua preparacao
ES2058139T3 (es) Compuestos complejos de bioflavonoides con fosfolipidos, su preparacion y uso, y composiciones farmaceuticas y cosmeticas que los contienen.
ATE9695T1 (de) Antihistamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE29215T1 (de) Diaethylpropionpraeparate mit verzoegerter wirkung.
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
DE69628163D1 (de) Nor-pregnane zur induzierung hypothalamischer effekte
MX9300407A (es) Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion.
PT98371A (pt) Processo para a preparacao de derivados 6-alcoxi de arabinofuranosil-guanina e de composicoes farmaceuticas que os contem
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
ES551434A0 (es) Proceso para la fabricacion de compuestos de espiro-hidantoina
MX9304355A (es) Compuestos heterociclicos.
ES2127263T3 (es) Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
IT1243413B (it) Derivati del glicerolo, un procedimento per la loro preparazione e composizioni terapeutiche che li contengono
SE8302580D0 (sv) Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning
ES2171743T3 (es) Derivados de amidinas e isotioureas como inhibidores de la enzima sintasa de oxido nitrico.
ES8200678A1 (es) Un procedimiento para la produccion de 10-(4-piperidinil)-10, 11-dihidro-dibenzo b,f 1,4 oxarepinas; tiazepinas y diaze-pinas.
DE69128254T2 (de) Antihypertensive benzopyran-derivate
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
ES2076248T3 (es) Dibenzofuranos substituidos y metodos para el uso de los mismos.
MX9305578A (es) Adsorbato a base de una mezcla de sustancias auxiliares y un principio activo no solido para la produccion de preparados medicamentosos.
ES2055440T3 (es) Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.
IT8621837A0 (it) Nuovi derivati biciclici del catecolo, procedimento per la loro preparazione e composizioni terapeutiche che li contengono.
IT1069050B (it) Esteri o-pirazolo-pirimidin-tion-tiol-fosforici,procedimento per la loro preparazione e loro impiego come insetticidi,acaricidi e nematocidi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 387808

Country of ref document: ES